Last updated: 11/04/2018 10:26:08
A Clinical Study to Evaluate Experimental Children's Toothpastes in an In-Situ Caries Model
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A Clinical Study to Evaluate Experimental Children's Toothpastes in an In-Situ Caries Model
Trial description: An in situ model will be used to evaluate and compare enamel remineralization of human enamel specimens after single use of experimental children's toothpastes.
Primary purpose:
Treatment
Trial design:
Crossover Assignment
Masking:
Single (Investigator)
Allocation:
Randomized
Primary outcomes:
Percentage surface microhardness recovery of test dentifrices relative to placebo dentifrice
Timeframe: Baseline to 4 hours
Secondary outcomes:
%SMHR of enamel specimens exposed to test treatments
Timeframe: Baseline to 4 hours
Percent net acid resistance (%NAR) of enamel specimens
Timeframe: Baseline to 4 hours
Enamel fluoride uptake
Timeframe: Baseline to 4 hours
Interventions:
Enrollment:
55
Primary completion date:
2012-31-05
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Newby EE, Martinez-Mier EA, Hara A, Lippert F, Kelly SA, Fleming N, Butler A, Bosma ML, Zero DT. A randomised clinical study to evaluate experimental children's toothpastes in an in-situ palatal caries model in children aged 11-14 years. Int Dent J. 2013 Dec;63 Suppl 2:31-8.
Newby EE, Martinez-Mier EA, Hara A, Lippert F, Kelly SA, Fleming N, Butler A, Bosma ML, Zero DT. A randomised clinical study to evaluate experimental children's toothpastes in an in-situ palatal caries model in children aged 11-14 years. Int Dent J. 2013 Dec;63 Suppl 2:31-8.
Medical condition
dental caries
Product
sodium fluoride
Collaborators
Not applicable
Study date(s)
February 2012 to May 2012
Type
Interventional
Phase
3
Participation criteria
Sex
Female & Male
Age
11 - 14 years
Accepts healthy volunteers
Yes
- Healthy males and females aged 11 to 14 inclusive who have an unstimulated salivary flow rate of at least 0.2 mL/minute and a stimulated salivary flow rate of at least 0.8 mL/minute (Screening Visit 1).
Inclusion and exclusion criteria
Inclusion criteria:
- Healthy males and females aged 11 to 14 inclusive who have an unstimulated salivary flow rate of at least 0.2 mL/minute and a stimulated salivary flow rate of at least 0.8 mL/minute (Screening Visit 1).
Trial location(s)
Location
Indiana University School of Dentistry
Indianapolis, IN, United States, 46202
Status
Study Complete
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Results posted on ClinicalTrials.gov
Recruitment status
Study complete
Actual primary completion date
2012-31-05
Actual study completion date
2012-31-05
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Additional information
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website